Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Anatomy and Physiology›Vas Deferens
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Vas Deferens

Anatomy and Physiology · NLM MeSH · updated 2026-10-31 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 5 min read

The excretory duct of the testes that carries spermatozoa.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (880 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

The excretory duct of the testes that carries spermatozoa. It rises from the scrotum and joins the seminal vesicles to form the ejaculatory duct.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Deferens, Vas; Ductus Deferens; Deferens, Ductus.

Where it fits in the MeSH classification

Broader topics
Genitalia, Male
See also
Vasectomy; Vasovasostomy

Related concepts

  • Spermatozoa
  • Scrotum
  • Seminal Vesicles

Research landscape

PubMed indexes 8,428 records tagged with the MeSH heading “Vas Deferens” (counts retrieved 2026-10-31). 244 of them (2.9%) were published from 2020 onward, and the busiest period so far is through 1999 with 6,501 records.

Reviews account for 324 records (3.8%) and meta-analyses for 9. Randomized controlled trials number 16 (0.2%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 6,501 records; 2000-2009: 1,134 records; 2010-2019: 549 records; 2020 onward: 244 records6,501through 19991,1342000-20095492010-20192442020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19996,501
2000-20091,134
2010-2019549
2020 onward244
Share of records by publication typeReviews: 3.8 percent; Meta-analyses: 0.1 percent; Randomized controlled trials: 0.2 percentReviews3.8% (324)Meta-analyses0.1% (9)Randomized controlled trials0.2% (16)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 8,428 PubMed records
TypeRecordsShare
Reviews3243.8%
Meta-analyses90.1%
Randomized controlled trials160.2%

Method: PubMed query "Vas Deferens"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.

Reading the evidence in anatomy and physiology

Anatomy describes how body structures are built and physiology describes how they normally work, so most findings here are descriptive or mechanistic rather than evidence about treatment. Much of what is known comes from dissection, imaging, tissue studies and experiments in animals, and measurements in healthy volunteers can differ from those in people with disease or at different ages. Normal ranges vary between individuals and populations. Check whether a result was measured in people or in another species, the age and health of the participants, and the method used.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
An atlas of cell types in the mouse epididymis and vas deferens
Rinaldi VD, Donnard E, Gellatly K, Rasmussen M, Kucukural A, Yukselen O, et al.
2020Research article
Design not recorded in structured metadata
77cc by
PMID 32729827 · DOI · PMC7426093
Genetics of the congenital absence of the vas deferens
Bieth E, Hamdi SM, Mieusset R
2021Review article
Design not recorded in structured metadata
71cc by
PMID 32025909 · DOI · PMC7864840
Large genomic rearrangements in the CFTR gene contribute to CBAVD
Taulan M, Girardet A, Guittard C, Altieri JP, Templin C, Beroud C, et al.
2007Research article
Design not recorded in structured metadata
36cc by
PMID 17448246 · DOI · PMC1876208
Vas deferens to rete testis anastomosis for obstructive azoospermia
Mesquita FC, Campos LR, Savio LF, Codrington J, White JT, Velasquez D, et al.
2024Research article
Design not recorded in structured metadata
0cc by
PMID 38598831 · DOI · PMC11152323

An atlas of cell types in the mouse epididymis and vas deferens [1]

Research article Rinaldi VD, Donnard E, Gellatly K, Rasmussen M, Kucukural A, Yukselen O, et al. · · 2020 · cited 77 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Following testicular spermatogenesis, mammalian sperm continue to mature in a long epithelial tube known as the epididymis, which plays key roles in remodeling sperm protein, lipid, and RNA composition.
Closing excerpt
Our dataset extends on existing knowledge of epididymal biology, and provides a wealth of information on potential regulatory and signaling factors that bear future investigation.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (149 words)

Following testicular spermatogenesis, mammalian sperm continue to mature in a long epithelial tube known as the epididymis, which plays key roles in remodeling sperm protein, lipid, and RNA composition. To understand the roles for the epididymis in reproductive biology, we generated a single-cell atlas of the murine epididymis and vas deferens. We recovered key epithelial cell types including principal cells, clear cells, and basal cells, along with associated support cells that include fibroblasts, smooth muscle, macrophages and other immune cells. Moreover, our data illuminate extensive regional specialization of principal cell populations across the length of the epididymis. In addition to region-specific specialization of principal cells, we find evidence for functionally specialized subpopulations of stromal cells, and, most notably, two distinct populations of clear cells. Our dataset extends on existing knowledge of epididymal biology, and provides a wealth of information on potential regulatory and signaling factors that bear future investigation.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 32729827 · DOI · PMC7426093

Genetics of the congenital absence of the vas deferens [2]

Review article Bieth E, Hamdi SM, Mieusset R · · 2021 · cited 71 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Congenital absence of the vas deferens (CAVD) may have various clinical presentations depending on whether it is bilateral (CBAVD) or unilateral (CUAVD), complete or partial, and associated or not with other abnormalities of the male urogenital tract.
Closing excerpt
How the dysfunction of CFTR, ADGRG2, or other genes such as SLC29A3 leads to this involution is the subject of various pathophysiological hypotheses that are discussed in this review.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (256 words)

Congenital absence of the vas deferens (CAVD) may have various clinical presentations depending on whether it is bilateral (CBAVD) or unilateral (CUAVD), complete or partial, and associated or not with other abnormalities of the male urogenital tract. CBAVD is usually discovered in adult men either during the systematic assessment of cystic fibrosis or other CFTR-related conditions, or during the exploration of isolated infertility with obstructive azoospermia. The prevalence of CAVDs in men is reported to be approximately 0.1%. However, this figure is probably underestimated, because unilateral forms of CAVD in asymptomatic fertile men are not usually diagnosed. The diagnosis of CAVDs is based on clinical, ultrasound, and sperm examinations. The majority of subjects with CAVD carry at least one cystic fibrosis-causing mutation that warrants CFTR testing and in case of a positive result, genetic counseling prior to conception. Approximately 2% of the cases of CAVD are hemizygous for a loss-of-function mutation in the ADGRG2 gene that may cause a familial form of X-linked infertility. However, despite this recent finding, 10-20% of CBAVDs and 60-70% of CUAVDs remain without a genetic diagnosis. An important proportion of these unexplained CAVDs coexist with a solitary kidney suggesting an early organogenesis disorder (Wolffian duct), unlike CAVDs related to CFTR or ADGRG2 mutations, which might be the result of progressive degeneration that begins later in fetal life and probably continues after birth. How the dysfunction of CFTR, ADGRG2, or other genes such as SLC29A3 leads to this involution is the subject of various pathophysiological hypotheses that are discussed in this review.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 32025909 · DOI · PMC7864840

Large genomic rearrangements in the CFTR gene contribute to CBAVD [3]

Research article Taulan M, Girardet A, Guittard C, Altieri JP, Templin C, Beroud C, et al. · · 2007 · cited 36 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundBy performing extensive scanning of whole coding and flanking sequences of the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene, we had previously identified point mutations in 167 out of 182 (91.
Closing excerpt
We have designed a simple test to specifically detect the presence or absence of the two rearrangements identified in this study.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (238 words)

BackgroundBy performing extensive scanning of whole coding and flanking sequences of the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene, we had previously identified point mutations in 167 out of 182 (91.7%) males with isolated congenital bilateral absence of the vas deferens (CBAVD). Conventional PCR-based methods of mutation analysis do not detect gross DNA lesions. In this study, we looked for large rearrangements within the whole CFTR locus in the 32 CBAVD patients with only one or no mutation.MethodsWe developed a semi-quantitative fluorescent PCR assay (SQF-PCR), which relies on the comparison of the fluorescent profiles of multiplex PCR fragments obtained from different DNA samples. We confirmed the gross alterations by junction fragment amplification and identified their breakpoints by direct sequencing.ResultsWe detected two large genomic heterozygous deletions, one encompassing exon 2 (c.54-5811_c.164+2186del8108ins182) [or CFTRdele2], the other removing exons 22 to 24 (c.3964-3890_c.4443+3143del9454ins5) [or CFTRdele 22_24], in two males carrying a typical CBAVD mutation on the other parental CFTR allele. We present the first bioinformatic tool for exon phasing of the CFTR gene, which can help to rename the exons and the nomenclature of small mutations according to international recommendations and to predict the consequence of large rearrangements on the open reading frame.ConclusionIdentification of large rearrangements further expands the CFTR mutational spectrum in CBAVD and should now be systematically investigated. We have designed a simple test to specifically detect the presence or absence of the two rearrangements identified in this study.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 17448246 · DOI · PMC1876208

Vas deferens to rete testis anastomosis for obstructive azoospermia [4]

Research article Mesquita FC, Campos LR, Savio LF, Codrington J, White JT, Velasquez D, et al. · · 2024

Abstract reading summary — source excerpts
Opening excerpt
PurposeThis video aims to present an in-depth, step-by-step tutorial on microsurgical reconstruction for obstructive azoospermia, featuring a distinctive case involving anastomosis from vas deferens to rete testis.
Closing excerpt
ConclusionsAnastomosis from vas deferens to rete testis emerges as a viable surgical reconstruction alternative for obstructive azoospermia, particularly when confronted with non-dilated tubules within the epididymis.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (237 words)

PurposeThis video aims to present an in-depth, step-by-step tutorial on microsurgical reconstruction for obstructive azoospermia, featuring a distinctive case involving anastomosis from vas deferens to rete testis. The primary aim of this endeavor is to offer thorough and practical insights for healthcare professionals and researchers within the realm of reproductive medicine. The video endeavors to disseminate expertise, methodologies, and perspectives that can be advantageous to individuals grappling with obstructive azoospermia, providing a significant contribution to the progress of reproductive medicine and the augmentation of existing treatment alternatives.Materials and methodsSurgical footage was recorded using the ORBEYE 4K 3D Orbital Camera System by Olympus America, with patient consent acquired for research purposes. Additionally, a retrospective examination of patient records was undertaken to compile relevant medical histories.ResultsThis video furnishes an exhaustive guide to microsurgical reconstruction for obstructive azoospermia, encompassing a distinctive instance of anastomosis from vas deferens to rete testis. State-of-the-art technology, such as the ORBEYE 4K 3D Orbital Camera, heightens procedural transparency, accentuating the significance of advanced instrumentation. The ethical underpinning is emphasized by obtaining patient consent for footage utilization, and a retrospective chart review augments the repository of valuable patient data. This comprehensive approach serves as an invaluable reservoir of knowledge for medical professionals and underscores excellence in clinical and ethical healthcare research.ConclusionsAnastomosis from vas deferens to rete testis emerges as a viable surgical reconstruction alternative for obstructive azoospermia, particularly when confronted with non-dilated tubules within the epididymis.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 38598831 · DOI · PMC11152323

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article CFTR mutations in men with congenital bilateral absence of the vas deferens (CBAVD): a systemic review and meta-analysis [5]
    Yu J, Chen Z, Ni Y, Li Z · Hum Reprod · 2012 · cited 141 times (Europe PMC)
  • Research article H(+)V-ATPase-dependent luminal acidification in the kidney collecting duct and the epididymis/vas deferens: vesicle recycling and transcytotic pathways [6]
    Brown D, Breton S · J Exp Biol · 2000 · cited 112 times (Europe PMC)
  • Research article The genetic basis of congenital bilateral absence of the vas deferens and cystic fibrosis [7]
    Oates RD, Amos JA · J Androl · 1994 · cited 92 times (Europe PMC)
  • Research article Congenital bilateral absence of the vas deferens as an atypical form of cystic fibrosis: reproductive implications and genetic counseling [8]
    de Souza DAS, Faucz FR, Pereira-Ferrari L, Sotomaior VS, Raskin S · Andrology · 2018 · cited 79 times (Europe PMC)
  • Research article Imaging of the seminal vesicle and vas deferens [9]
    Kim B, Kawashima A, Ryu JA, Takahashi N, Hartman RP, King BF · Radiographics · 2009 · cited 76 times (Europe PMC)
  • Research article Mutations in the cystic fibrosis gene in men with congenital bilateral absence of the vas deferens [10]
    De Braekeleer M, Férec C · Mol Hum Reprod · 1996 · cited 52 times (Europe PMC)

References

  1. Rinaldi VD, Donnard E, Gellatly K, Rasmussen M, Kucukural A, Yukselen O, et al.. An atlas of cell types in the mouse epididymis and vas deferens. . 2020. PMID 32729827 · DOI · PMC7426093
  2. Bieth E, Hamdi SM, Mieusset R. Genetics of the congenital absence of the vas deferens. . 2021. PMID 32025909 · DOI · PMC7864840
  3. Taulan M, Girardet A, Guittard C, Altieri JP, Templin C, Beroud C, et al.. Large genomic rearrangements in the CFTR gene contribute to CBAVD. . 2007. PMID 17448246 · DOI · PMC1876208
  4. Mesquita FC, Campos LR, Savio LF, Codrington J, White JT, Velasquez D, et al.. Vas deferens to rete testis anastomosis for obstructive azoospermia. . 2024. PMID 38598831 · DOI · PMC11152323
  5. Yu J, Chen Z, Ni Y, Li Z. CFTR mutations in men with congenital bilateral absence of the vas deferens (CBAVD): a systemic review and meta-analysis. Hum Reprod. 2012. PMID 22081250 · DOI
  6. Brown D, Breton S. H(+)V-ATPase-dependent luminal acidification in the kidney collecting duct and the epididymis/vas deferens: vesicle recycling and transcytotic pathways. J Exp Biol. 2000. PMID 10600682 · DOI
  7. Oates RD, Amos JA. The genetic basis of congenital bilateral absence of the vas deferens and cystic fibrosis. J Androl. 1994. PMID 8188533 · DOI
  8. de Souza DAS, Faucz FR, Pereira-Ferrari L, Sotomaior VS, Raskin S. Congenital bilateral absence of the vas deferens as an atypical form of cystic fibrosis: reproductive implications and genetic counseling. Andrology. 2018. PMID 29216686 · DOI · PMC5745269
  9. Kim B, Kawashima A, Ryu JA, Takahashi N, Hartman RP, King BF. Imaging of the seminal vesicle and vas deferens. Radiographics. 2009. PMID 19605659 · DOI
  10. De Braekeleer M, Férec C. Mutations in the cystic fibrosis gene in men with congenital bilateral absence of the vas deferens. Mol Hum Reprod. 1996. PMID 9239681 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-31.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Seminal VesiclesAnatomy and Physiology
  • Spermatic CordAnatomy and Physiology
  • EpididymisAnatomy and Physiology
  • Leydig CellsAnatomy and Physiology
  • PenisAnatomy and Physiology
  • ProstateAnatomy and Physiology

All 542 articles in Anatomy and Physiology →

At a glance

8,428
PubMed records on this heading
3%
published since 2020
324
review articles
16
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-31; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Seminal VesiclesAnatomy and Physiology
  • Spermatic CordAnatomy and Physiology
  • EpididymisAnatomy and Physiology
  • Leydig CellsAnatomy and Physiology
  • PenisAnatomy and Physiology

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support